Health

PROMs as Clinical Trial Endpoints: Added Value

by Archynetys Health Desk

Nature Medicine, Published online: 25 August 2025; Two: 10.1038/S41591-025-03906-1

Asking patients about their symptoms, functioning and well-being during clinical trials can influence trial outcomes, regulatory decisions and clinical practice.

The Archynetys Health Desk covers public health, medical research, healthcare systems, wellness trends, and science-backed developments that affect readers globally. This desk applies added care to sourcing, evidence, nuance, and plain-language explanation, especially on high-impact health topics.

Related Posts

Personalized mRNA vaccine shows 90% survival in pancreatic...

Indonesia’s obesity rate rises to 23.4% in 2026,...

SIIDB’s SII-007 Flu Antibody Achieves Industrial Use After...

Childfree women in Sweden face stigma despite confidence...

Dengue Cases Rise in Indonesian Workplaces Amid Poor...

U.S. health officials block CDC study showing vaccines...

Personalized mRNA vaccine keeps pancreatic cancer patients alive...

Kennedy Defends Measles Vaccine Recommendation While Deflecting Past...

Cambodia confirms fourth H5N1 human case in 2026...

Sunlight Alone Often Fails to Restore Vitamin D...

Leave a Comment